Corticosteroids as Adjunctive Therapy for Severe Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome: A Double-Blind, Placebo-Controlled Trial

New England Journal of Medicine

Volumn 323, Issue 21, 1990, Pages 1444-1450

  Gagnon, Suzanne ^a   Boota, Ahmad M ^a   Fischl, Margaret A ^a   Baier, Horst ^a   Kirksey, Otis W ^b   la Voie, Lawrence ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Memorial Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT THERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADRENAL CORTEX HORMONES; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; METHYLPREDNISOLONE; MIDDLE AGE; PNEUMONIA, PNEUMOCYSTIS CARINII; RESPIRATORY INSUFFICIENCY; SUPPORT, NON-U.S. GOV'T; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0025144705     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199011223232103     Document Type: Article

References (28)

1. Glatt AE, Chirgwin K, Landesman SH. Treatment of infections associated with human Immunodeficiency virus. N Engl J Med 1988; 318: 1439–48.
2. Mills J. Pneumocystis carinii and Toxoplasma gondii in patients with AIDS. Rev Infect Dis 1986; 8: 1001–11.
3. Murray JF, Felton CP, Garay SM, et al. Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 1984; 310: 1682–8.
4. Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, Stover DE. Pulmonary complications of the acquired immunodeficiency syndrome: an update: report of the second National Heart, Lung, and Blood Institute workshop. Am Rev Respir Dis 1987; 135: 504–9.
5. Wofsy CB. Use of trimethoprim–sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1987; 9: Suppl 2: S184–S194.
6. Kaplan LD, Wofsy CB, Volberding PA. Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA 1987; 257: 1367–74.
7. Haverkos HW. Assessment of therapy for Pneumocystis carinii pneumonia: PCP Therapy Project Group. Am J Med 1984; 76: 501–8.
8. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim–sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1988; 109: 280–7.
9. Glatt AE, Chirgwin K. Pneumocystis carinii pneumonia in human immunodeficiency virus–infected patients. Arch Intern Med 1990; 150: 271–9.
10. Davey RT Jr, Masur H. Recent advances in the diagnosis, treatment and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1990; 34: 499–504.
11. Brenner M, Ognibene FP, Lack EE, et al. Prognostic factors and life expectancy of patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1987; 136: 1199–206.
12. Kales CP, Murren JR, Torres RA, Crocco JA. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 1987; 147: 1413–7.
13. Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia: diagnostic and prognostic significance. Am Rev Respir Dis 1988; 137: 796–800.
14. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing patterns of utilization. Am Rev Respir Dis 1986; 134: 891–6.
15. Schein RMH, Fischl MA, Pitchenik AE, Sprung CL. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 1986; 14: 1026–7.
16. Luce JM, Wachter RM, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: time for a reassessment? Am Rev Respir Dis 1988; 137: 1261–3.
17. el-Sadr W, Simberkoff MS. Survival and prognostic factor in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Respir Dis 1988; 137: 1264–7.
18. Efferen LS, Nadarajad D, Palat DS. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective. Am J Med 1989; 87: 401–4.
19. el-Sadr W, Sidhu G, Diamond G, et al. High dose-corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. AIDS Res 1986; 2: 349–55.
20. MacFadden DK, Edelson JD, Hyland RH, Rodriguez CH, Inouye T, Rebuck AS. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Lancet 1987; 1: 1477–9.
21. Montaner JSG, Russell JA, Lawson L, Ruedy J. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a potential role for systemic corticosteroids. Chest 1989; 95: 881–4.
22. Rankin JA, Pella JA. Radiographic resolution of Pneumocystis carinii pneumonia in response to corticosteroid therapy. Am Rev Respir Dis 1987; 136: 182–3.
23. Walmsley S, Salit IE, Brunton J. The possible role of corticosteroid therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome (AIDS). J Acquir Immune Defic Syn 1988; 1: 354–60.
24. Montaner JSG, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 113: 14–20.
25. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949.
26. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames: Iowa State University Press, 1967.
27. Flick MR, Murray JF. High-dose corticosteroid therapy in the adult respiratory distress syndrome. JAMA 1984; 251: 1054–6.
28. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565–70.